Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right-sided lesion dissection.

Among Medicare beneficiaries with IBD, Black, Asian, and Hispanic patients have lower health care utilization patterns than White patients.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

Data from a phase 3 study indicated the microbiota-based live biotherapeutic RBL was safe and efficacious for recurrent CDI prevention in immunocompromised patients.

For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities persist.

According to a recent study, glucagon-like peptide-1 receptor agonists are associated with a reduction in alcohol intake.

Trump signed an executive order instructing the HHS to align Medicare payments for drugs with the lowest prices paid by other nations.

Eating a healthy diet is linked to girls having their first menstrual period at an older age than those who consume a less healthy diet.

The FDA has granted Orphan Drug designation to TPST-1495, dual receptor inhibitor of prostaglandin signaling, for the treatment of familial adenomatous polyposis.

Data-driven clustering reveals distinct obesity phenotypes with unique clinical, behavioral, microbiome features, and differential GLP-1 responses.

Children with DKA had an increased likelihood of positive celiac serologies, and those with positive tTG-IgA had higher HbA1c concentrations.

The Liver Transplant Comorbidity Index, developed from FrAILT study results, identified patients at high risk for mortality at 3 years post-liver transplant.